Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
D J DiekemaSENTRY Partcipants Group

Abstract

Between January 1997 and December 1999, bloodstream isolates from 15,439 patients infected with Staphylococcus aureus and 6350 patients infected with coagulase-negative Staphylococcus species (CoNS) were referred by SENTRY-participating hospitals in the United States, Canada, Latin America, Europe, and the Western Pacific region. S. aureus was found to be the most prevalent cause of bloodstream infection, skin and soft-tissue infection, and pneumonia in almost all geographic areas. A notable increase in methicillin (oxacillin) resistance among community-onset and hospital-acquired S. aureus strains was observed in the US centers. The prevalence of methicillin (oxacillin)-resistant S. aureus varied greatly by region, site of infection, and whether the infection was nosocomial or community onset. Rates of methicillin resistance were extremely high among S. aureus isolates from centers in Hong Kong and Japan. Uniformly high levels of methicillin resistance were observed among CoNS isolates. Given the increasing multidrug resistance among staphylococci and the possible emergence of vancomycin-resistant strains, global strategies are needed to control emergence and spread of multiply resistant staphylococci.

Citations

Dec 17, 2009·Cellular and Molecular Life Sciences : CMLS·Michael R Yeaman
Oct 9, 2009·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·T HirschL Steinstraesser
Jan 6, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Shawna F GravesFrank R DeLeo
Nov 15, 2011·Seminars in Immunopathology·Brad Spellberg, Robert Daum
Nov 15, 2011·Seminars in Immunopathology·Kevin M Rigby, Frank R DeLeo
Nov 19, 2011·Seminars in Immunopathology·Michael Otto
Mar 23, 2010·World Journal of Urology·Gernot BonkatAndreas F Widmer
Jun 23, 2010·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·T Ness
Feb 1, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B P HowdenM L Grayson
Dec 13, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M H Kollef
Jun 1, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A Y PelegF Huygens
Jun 1, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K Levi, K J Towner
Aug 5, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L PatteetM Ieven
Dec 4, 2009·Current Diabetes Reports·Frank L BowlingAndrew J M Boulton
Nov 16, 2002·Current Infectious Disease Reports·Fu-Yu Chiang, Michael Climo
Oct 6, 2004·Current Infectious Disease Reports·Thomas J ScharschmidtJoseph P Myers
Nov 13, 2004·Current Infectious Disease Reports·Philip M Polgreen, Loreen A Herwaldt
Oct 28, 2009·Current Infectious Disease Reports·Orna Reichman, Jack D Sobel
Apr 15, 2004·International Journal of Antimicrobial Agents·L Clifford McDonaldUNKNOWN TSAR Participating Hospitals
Jul 11, 2013·International Journal of Antimicrobial Agents·Carina Vingsbo Lundberg, Niels Frimodt-Møller
Jan 22, 2003·Biochemical and Biophysical Research Communications·Lorenzo GalluzziMatti Karp
Dec 19, 2001·Lancet·D J Diekema, R N Jones
Mar 9, 2010·Lancet·Frank R DeLeoHenry F Chambers
Feb 23, 2002·Diagnostic Microbiology and Infectious Disease·Ronald N JonesTamara R Anderegg
Jun 8, 2002·Diagnostic Microbiology and Infectious Disease·Charles H BallowUNKNOWN North American ZAPS Research Group
May 3, 2003·International Journal of Antimicrobial Agents·D J HobanUNKNOWN Surveillance Study Research Group
Jun 7, 2003·International Journal of Antimicrobial Agents·Dilip Nathwani, Glenn S Tillotson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
M B EdmondR P Wenzel
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
F J SchmitzA C Fluit
© 2021 Meta ULC. All rights reserved